Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,000 shares at $37.24 ($372K) on 2015-12-01, disclosed to the SEC on 2015-12-03.
Scheduled sale ($372k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |